Form D · Other Investment Fund

FIRST BIOMED L P

New York, NY · CIK 0001170241

Offering snapshot reported Feb 20, 2024 · SEC filing

Reported sold
$11.7M
Indefinite offering
Investors reported
26
Form D · investor count
Minimum accepted
$5K
Reported outside-investor minimum
First sale
Feb 1, 2010
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$5.86M$11.7MDec 13, 2022: $11,723,343.00Dec 13, 2022Dec 12, 2023: $11,728,343.00Feb 20, 2024: $11,728,343.00Feb 20, 2024

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Feb 20, 2024Amendment$11,728,343$0vs Dec 12, 202326SEC filing
Dec 12, 2023Amendment$11,728,343$5,000vs Dec 13, 202226SEC filing
Dec 13, 2022Initial$11,723,343No comparison26SEC filing
Mar 16, 2007PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity, Pooled investment fund
Exemptions
06b, 3C, 3C.7
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-467227
Portfolio Managers for separate accounts invested in the fund receive compensation for amounts invested in the fund but do not separately receive a portfolio management fee at an account level.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
N/ANoneFirst Manhattan Securities LLC · CRD 1845

Source: Form D, filed Feb 20, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Samuel Colin Executive
N/A First Manhattan Co. Promoter
N/A First Manhattan Co. Llc Promoter

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
399 Park Avenue
New York, NY, 10022